RFQ - HR MRO B-54030.docx

DOCX document 18 KB Posted

Attached to
SP DHS OHR MRO SERVICES
Solicitation number
27-444DHS-CONTO-B-54030
Issued by
Illinois

About this file

This is a Request for Quote (RFQ B-54030) issued by the Illinois Department of Human Services (DHS), Office of Human Resources, seeking occasional services of a qualified Medical Review Officer (MRO) to review and verify laboratory-confirmed nonnegative drug test results, adulterated/substituted results, and invalid results submitted via the Quest database. The selected MRO must be a licensed physician (Doctor of Medicine or Doctor of Osteopathy) with specialized training in DOT drug testing regulations, current certification from a nationally recognized MRO certification board, and demonstrated knowledge of Federal Motor Carrier Safety Administration (FMCSA) procedures and chain of custody protocols. Key service requirements include conducting initial review and verification of test results, completing interviews and determinations within DOT-mandated timeframes, reporting verified results to the Designated Employer Representative (DER) without unnecessary delays, and reviewing a minimum of 5% of negative results to ensure quality assurance. The MRO must maintain current requalification training every five years and comply with all DOT regulations under 49 CFR Part 40, Subpart G. No subcontractors are permitted; the vendor must be capable of performing all services directly.

The RFQ does not specify pricing terms, contract duration, renewal options, response deadlines, award dates, or funding amounts in the provided documentation. The position is designated for occasional services rather than full-time employment, indicating an as-needed consulting arrangement. No incumbent information, set-asides, or specific funding sources are detailed in this file.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Request for Quote B-54030

The selected qualified Medical Review Officer (MRO) must:

· be a Doctor of Medicine or a Doctor of Osteopathy

· be a licensed physician who can review drug test results and ensure the accuracy and integrity of the drug testing process

· have specialized training in drug testing regulations and the medical review of laboratory results

· have passed a certification examination administered by a nationally recognized MRO certification board such as the Medical Review Officer Certification Council or the American Association of Medical Review Officers

· be aware and stay current on DOT drug testing program procedures and regulations, collection, chain of custody and recordkeeping protocols

· must complete requalification training every five years, ensuring they remain up to date with regulatory changes, testing protocols and best practices in medical review

DOT (49 CFR Part 40, Subpart G)

· Initial review and verification:

· review and verify laboratory‑confirmed non‑negative drug test results, adulterated/substituted results, and invalid results promptly after receiving them from the laboratory Federal Motor Carrier Safety Administration

· Interviews and determinations:

· If interview is required, must complete the verification process and issue a determination within the timeframes set by the DOT for the specific type of result (e.g., positive, adulterated, substituted, invalid) eCFR

· Reporting:

· Verified results must be reported to the DER in a timely manner—DOT regulations require that MROs transmit reports to the employer as soon as possible after making a determination, without unnecessary delays Federal Motor Carrier Safety Administration

· Negative and negative/dilute results:

· must review at least 5% of negative results reported by staff to ensure proper performance, and all specimens requiring corrective action must be reviewed personally www.mrocc.org.

Federal Motor Carrier Safety Administration (FMCSA)

· FMCSA regulations mirror DOT requirements, emphasizing timely review and reporting to protect the integrity of the drug testing process and ensure compliance with safety standards Federal Motor Carrier Safety Administration

Key points for compliance

· cannot delay verification beyond the regulatory deadlines; failure to meet these timeframes can result in administrative actions or loss of certification

· timeframes apply to both positive and negative results, including special cases like adulteration, substitution, and invalid tests

· must balance prompt action with thorough review, especially when interviews or additional lab testing are needed

· maintain internal tracking of when results are received, when interviews occur, and when reports are sent, ensuring all steps are completed within the regulatory window

File details come from the government source that posted it. Updated .